Fibrobiologics（FBLG.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

股东类型

公众及其他79.70%
个人与内部人士8.88%
机构投资者6.56%
私营企业4.86%

主要股东

主要股东最新
股东
Golden Knight Incorporated, L.P.	4.85%	33.75 万	0.70%	+0	2026/07/08
Hamid KhojaChief Scientific Officer	4.33%	30.16 万	4.28%	+29.85 万	2026/09/15
Peter O’HeeronFounder, Chairperson & CEO	4.28%	29.79 万	0.62%	+0	2026/07/08
The Lind Partners, LLC	2.27%	15.80 万	--	+15.80 万	2026/04/02
Cascade Financial Partners, LLC	1.56%	10.88 万	1.10%	+9.24 万	2026/06/30
Fund Evaluation Group, LLC	0.74%	5.18 万	0.73%	+0	2026/06/30
Vanguard Capital Management, LLC	0.49%	3.41 万	1.62%	-3.99 万	2026/06/30
Geode Capital Management, LLC	0.44%	3.03 万	0.41%	+690.00	2026/06/30
Qube Research & Technologies Ltd	0.35%	2.43 万	0.35%	+2.43 万	2026/06/30
BlackRock, Inc.	0.26%	1.82 万	0.44%	-6,409.00	2026/06/30
Abante Asesores Gestion	0.20%	1.36 万	0.19%	+0	2025/12/31
Ruben GarciaGeneral Counsel	0.13%	9,000.00	0.02%	+0	2026/07/08
Barclays Bank Plc	0.10%	7,243.00	--	+7,243.00	2026/06/30
Tower Research Capital Europe Limited	0.07%	4,728.00	0.05%	+4,268.00	2026/06/30
Richard CilentoIndependent Director	0.07%	4,662.00	<0.01%	+0	2026/07/08
Jason DavisChief Financial Officer	0.05%	3,500.00	<0.01%	+0	2026/07/08
Osaic Wealth, Inc.	0.03%	2,404.00	0.03%	+2,250.00	2026/06/30
Royal Bank of Canada	0.02%	1,522.00	0.02%	+1,336.00	2026/06/30
UBS Asset Management AG	0.02%	1,073.00	0.15%	-4,648.00	2026/06/30
Matthew LinkFormer Independent Director	<0.01%	375.00	<0.01%	+0	2026/04/24